Drug class · Oncology & immunology
Kinase inhibitors Drug Codes & NDCs
Small-molecule drugs that inhibit one or more protein kinases. Most are oral products dispensed by pharmacies.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lytgobifutibatinib | Futibatinib 16 mg/1 | TabletOral | TAIHO PHARMACEUTICAL CO., LTD. | 64842-0127 |
| Mekinisttrametinib | Trametinib dimethyl sulfoxide .5 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-1105 |
| Mekinisttrametinib | Trametinib dimethyl sulfoxide 2 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-1112 |
| Mekinisttrametinib | Trametinib dimethyl sulfoxide .05 mg/mL | Powder, For solutionOral | Novartis Pharmaceuticals Corporation | 0078-1161 |
| Nerlynxneratinib | Neratinib maleate anhydrous 40 mg/1 | TabletOral | Puma Biotechnology, Inc. | 70437-240 |
| Nexavarsorafenib | Sorafenib 200 mg/1 | Tablet, Film coatedOral | Bayer HealthCare Pharmaceuticals Inc. | 50419-488 |
| Nexavarsorafenib | Sorafenib 200 mg/1 | Tablet, Film coatedOral | Bayer HealthCare Pharmaceuticals Inc. | 50419-489 |
| nilotinib | Nilotinib hydrochloride monohydrate 150 mg/1 | CapsuleOral | Torrent Pharmaceuticals Limited | 13668-710 |
| nilotinib | Nilotinib hydrochloride monohydrate 200 mg/1 | CapsuleOral | Torrent Pharmaceuticals Limited | 13668-711 |
| Nilotinib | Nilotinib 150 mg/1 | CapsuleOral | Camber Pharmaceuticals, Inc. | 31722-779 |
| Nilotinib | Nilotinib 200 mg/1 | CapsuleOral | Camber Pharmaceuticals, Inc. | 31722-780 |
| Nilotinib | Nilotinib hydrochloride monohydrate 50 mg/1 | CapsuleOral | Dr. Reddy's Laboratories Inc | 43598-055 |
| Nilotinib | Nilotinib hydrochloride monohydrate 150 mg/1 | CapsuleOral | Dr. Reddy's Laboratories Inc | 43598-455 |
| Nilotinib | Nilotinib hydrochloride monohydrate 200 mg/1 | CapsuleOral | Dr. Reddy's Laboratories Inc | 43598-456 |
| Nilotinib | Nilotinib 150 mg/1 | CapsuleOral | Apotex Corp. | 60505-3801 |
| Nilotinib | Nilotinib 200 mg/1 | CapsuleOral | Apotex Corp. | 60505-3802 |
| Nilotinib | Nilotinib 50 mg/1 | CapsuleOral | Apotex Corp. | 60505-3803 |
| Nilotinib | Nilotinib 50 mg/1 | CapsuleOral | Cipla USA Inc. | 69097-030 |
| Nilotinib | Nilotinib 150 mg/1 | CapsuleOral | Cipla USA Inc. | 69097-031 |
| Nilotinib | Nilotinib 200 mg/1 | CapsuleOral | Cipla USA Inc. | 69097-032 |
| nilotinib | Nilotinib 50 mg/1 | CapsuleOral | Novadoz Pharmaceuticals LLC | 72205-237 |
| nilotinib | Nilotinib 150 mg/1 | CapsuleOral | Novadoz Pharmaceuticals LLC | 72205-238 |
| nilotinib | Nilotinib 200 mg/1 | CapsuleOral | Novadoz Pharmaceuticals LLC | 72205-239 |
| nilotinib | Nilotinib 150 mg/1 | CapsuleOral | AvKARE | 73190-033 |
| nilotinib | Nilotinib 200 mg/1 | CapsuleOral | AvKARE | 73190-034 |